Monthly revenue and year-on-year change for ECV (6689) and Navicare Biotech (8472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | ECV | YoY | Navicare Biotech | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$1.23 billion | +15.8% | NT$51.5 million | +0.8% |
| Sep 2026 | NT$1.13 billion | +6.2% | NT$45.2 million | -28.1% |
| Aug 2026 | NT$1.19 billion | +20.3% | NT$55.6 million | +121.3% |
| Jul 2026 | NT$1.33 billion | +42.2% | NT$48.1 million | +5.6% |
| Jun 2026 | NT$1.07 billion | +4.4% | NT$47.5 million | -20.7% |
| May 2026 | NT$1.03 billion | -0.3% | NT$38.6 million | +7.3% |
| Apr 2026 | NT$1.02 billion | -11.2% | NT$39.8 million | -11.8% |
| Mar 2026 | NT$1.03 billion | -8.2% | NT$47.3 million | +11.1% |
| Feb 2026 | NT$913.4 million | -11.0% | NT$47 million | +202.3% |
| Jan 2026 | NT$1.05 billion | +0.5% | NT$28.5 million | +30.8% |
| Dec 2025 | NT$1.04 billion | -15.5% | NT$41.3 million | +39.8% |
| Nov 2025 | NT$969 million | -14.1% | NT$30.9 million | -4.8% |
| Oct 2025 | NT$1.06 billion | -10.1% | NT$51 million | +128.1% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16